- Home
- INTG vs NRBO Comparison
INTG vs NRBO Comparison
Compare INTG & NRBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTG
- NRBO
- Stock Information
- Founded
- INTG 1965
- NRBO N/A
- Country
- INTG United States
- NRBO United States
- Employees
- INTG N/A
- NRBO N/A
- Industry
- INTG Building operators
- NRBO Biotechnology: Pharmaceutical Preparations
- Sector
- INTG Real Estate
- NRBO Health Care
- Exchange
- INTG Nasdaq
- NRBO Nasdaq
- Market Cap
- INTG 30.8M
- NRBO 27.9M
- IPO Year
- INTG N/A
- NRBO N/A
- Fundamental
- Price
- INTG $14.34
- NRBO $2.46
- Analyst Decision
- INTG
- NRBO Strong Buy
- Analyst Count
- INTG 0
- NRBO 1
- Target Price
- INTG N/A
- NRBO $10.00
- AVG Volume (30 Days)
- INTG 6.3K
- NRBO 34.1K
- Earning Date
- INTG 11-13-2024
- NRBO 11-07-2024
- Dividend Yield
- INTG N/A
- NRBO N/A
- EPS Growth
- INTG N/A
- NRBO N/A
- EPS
- INTG N/A
- NRBO N/A
- Revenue
- INTG $59,536,000.00
- NRBO N/A
- Revenue This Year
- INTG N/A
- NRBO N/A
- Revenue Next Year
- INTG N/A
- NRBO N/A
- P/E Ratio
- INTG N/A
- NRBO N/A
- Revenue Growth
- INTG 0.93
- NRBO N/A
- 52 Week Low
- INTG $13.65
- NRBO $2.08
- 52 Week High
- INTG $28.85
- NRBO $6.75
- Technical
- Relative Strength Index (RSI)
- INTG 44.26
- NRBO 39.90
- Support Level
- INTG $14.18
- NRBO $2.37
- Resistance Level
- INTG $14.41
- NRBO $2.99
- Average True Range (ATR)
- INTG 0.47
- NRBO 0.30
- MACD
- INTG 0.08
- NRBO 0.00
- Stochastic Oscillator
- INTG 49.23
- NRBO 22.22
About INTG Intergroup Corporation (The)
The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.
About NRBO NeuroBo Pharmaceuticals Inc.
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.